Skip to main content
ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.386
-0.022 (-5.42%)
At close: Nov 20, 2024, 4:00 PM
0.396
+0.010 (2.51%)
After-hours: Nov 20, 2024, 6:25 PM EST

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies had revenue of 5.26M CAD in the quarter ending July 31, 2024, a decrease of -7.47%. This brings the company's revenue in the last twelve months to 24.09M, up 11.21% year-over-year. In the fiscal year ending April 30, 2024, ImmunoPrecise Antibodies had annual revenue of 24.52M with 18.65% growth.

Revenue (ttm)
24.09M CAD
Revenue Growth
+11.21%
P/S Ratio
0.58
Revenue / Employee
238,545 CAD
Employees
101
Market Cap
11.13M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Apr 30, 202424.52M3.85M18.65%
Apr 30, 202320.67M1.30M6.72%
Apr 30, 202219.36M1.45M8.11%
Apr 30, 202117.91M3.85M27.42%
Apr 30, 202014.06M3.13M28.66%
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro
Apr 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
China Jo-Jo Drugstores 154.54M
Trinity Biotech 59.13M
Sol-Gel Technologies 11.71M
MSP Recovery 10.73M
Aspira Women's Health 8.92M
QT Imaging Holdings 4.04M
Immuron 3.27M
Talphera 281.00K
Revenue Rankings

IPA News

More News